glp 1 and binge eating disorder GLP-1s may reduce similar behaviours in people living with obesity, suggests the most comprehensive systematic review and meta-analysis to date, published in eClinicalMedicine. Find out more 👉 http://spkl.io/61897yUsZ Figure Nutritional priorities to support GLP-1

Biomed Pharmacother 89:19

Sermorelin is a type peptide therapy that acts as an analog of growth hormone-releasing hormone (GHRH), stimulating the pituitary gland to produce and release more of the bodys own human growth hormone (HGH)

And as GLP-1s are proving beneficial in other disorders including cardiovascular disease, demand is likely to continue to increase

doi: 10.2337/dc20-0498

It also supports better leg arterial circulation in those with compromised blood flow

In addition, levels of Toll Like Receptor 4 (TLR4) and inflammatory factors, such as Nuclear Factor B (NF-B), IL-6 and Monocyte Chemoattractant Protein-1 (MCP-1), were also significantly decreased compared to the untreated PE group